KERLONE

This brand name is authorized in France, Germany, Tunisia.

Active ingredients

The drug KERLONE contains one active pharmaceutical ingredient (API):

1	Betaxolol UNII 6X97D2XT0O - BETAXOLOL HYDROCHLORIDE
	Betaxolol is a cardioselective Beta1 receptor blocker which, when applied topically to the eye, lowers intraocular pressure. It is thought to produce this effect by reducing the rate of production of aqueous humour.
	Read more about Betaxolol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
KERLONE Tablet	MPI, US: SPL/Old	Web Search

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AB05	Betaxolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02707117
FR	Base de données publique des médicaments	67702384
TN	Direction de la Pharmacie et du Médicament	9263081